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Summary. Antigens from Candida albicans blastoconidia and germ tubes were identified by two-dimensional elec-
trophoresis and Western blotting and characterized by microsequencing, reactivity with concanavalin A, and a panel of human
sera. Antigens identified included a polydispersed area in the acidic high-molecular-mass regions of blastoconidium and
germ-tube extracts, and 16 antigens varying in molecular masses and isoelectric points (pIs). The majority of the detected
antigens, especially those in the polydispersed region, showed mannosyl groups, as determined by concanavalin A reactivity.
Antibodies present in sera from patients with invasive candidiasis showed high reactivity with a number of antigens not
detected with sera from blood donors. Eight of the 16 antigens could be identified by reactivity with monoclonal antibodies
or by microsequencing. Five antigens showed homology with five enzymes previously described as antigens in C. albicans:
enolase, phosphoglycerate kinase, malate dehydrogenase, and two isoforms of the fructose biphosphate aldolase. However,
to our knowledge, this is the first report of the immunogenic activity of a kexin precursor, a mitochondrial complex I chap-
erone, and a diacylglycerol kinase catalytic domain from C. albicans. Antigens described in this study may be of potential
interest for the serodiagnosis of invasive candidiasis. [Int Microbiol 2007; 10(2):103-108]
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Introduction
The increasing prevalence of yeast infections is a cause of
concern among clinicians, researchers, and patients. Candida
albicans has become a relevant cause of nosocomial infec-
tions [11,28]; however, despite the growing clinical impor-
tance of Candida species, many types of yeast-host interac-
tions are poorly understood. Diagnosis of invasive Candida
infections may be difficult due to the variability and lack of
specificity of clinical presentations. A definitive diagnosis is
often not reached until late in the infection, with subsequent
delays in the initiation of therapy. This, in turn, results in
substantial morbidity and mortality. 
Several non-culture approaches have been investigated in
the search for a method to obtain an early diagnosis of inva-
sive candidiasis [27]. These techniques include the detection
of β(1,3)D-glucan [20], D-arabinitol [5], enolase [30], DNA
[16], antigens, and antibodies [27]. Nevertheless, each tech-
nique has its limitations and none has found widespread clin-
ical use. The clinical application of antibody detection in
invasive candidiasis has been limited by problems of speci-
ficity and sensitivity [27]. One strategy to increase specifici-
ty has been the detection of antibodies to complex antigens
of C. albicans germ tubes [7,9]. In previous studies, we
described the use of SDS-PAGE to identify and characterize
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a high-molecular-mass component of the germ-tube cell wall
[2,25,26], and we demonstrated that detection of antibodies
against this antigen is useful in the serodiagnosis of invasive
candidiasis [7,9]. 
Two-dimensional electrophoresis (2-DE) has been used
to study the protein composition and antigenicity of extracts
from C. albicans blastoconidia and germ tubes [1,15,22,23].
Although many proteins have been identified as antigenic for
humans [24], little attention has been devoted to characteriz-
ing the antigenic differences between germ tubes and blasto-
conidia, although these differences may be useful in the sero-
diagnosis of invasive candidiasis. In this study, we report the
use of 2-DE to identify several mannoprotein antigens specif-
ically expressed in one of the two growth phases of C. albi-
cans. The approach may be of interest for the serodiagnosis
of invasive candidiasis. 
Materials and methods
Strain and culture conditions. Candida albicans Universidad del
País Vasco (UPV) reference strain no. 1413 [1] was used in all the experi-
ments. Blastoconidia were grown at 24°C in Sabouraud dextrose broth for
24 h in a rotary shaker (120 rpm). Harvested cells were washed twice and the
pellet was stored at –40°C until used. For germ-tube induction, blastoconidia
were grown at a concentration of 106 cells/ml in medium 199 at 37°C for 4 h.
Under these conditions, at least 95% of the blastoconidia germinated.
Antigen extraction. Suspensions of 1010 cells/ml in 500 ml of sample
buffer (9 M urea, 2% β-mercaptoethanol, 2% pharmalyte 3–10, and 2%
NP40) were sonicated in an ice bath at intervals of 20 s for 5 min at 60 W
and centrifuged for 20 min at 11,000 ×g. Supernatants containing the anti-
genic mixtures were stored at –80°C. Total protein was determined by the
Bradford assay [3]. 
Human sera. Sera from ten patients with microbiologically proven sys-
temic candidiasis and six sera from blood donors were used in the experi-
ment [7]. 
Isoelectric focusing and 2-D PAGE. Isoelectric focusing (IEF) was
carried out according to Barea et al. [1] in an immobilized linear pH 3-10
gradient (IPG strips of 18 cm, GE Healthcare, Uppsala, Sweden) by a mod-
ification of the method described by Görg et al. [8]. The IPG strips were
equilibrated in 10 ml of 0.05 M Tris-HCl buffer, pH 6.8, containing 6 M
urea, 1% (w/v) SDS, 30% (w/v) glycerol, and 2% β-mercaptoethanol. After
15 min, the procedure was repeated with another 10 ml of equilibration
buffer containing 240 mM iodoacetamide and 0.5% (w/v) bromophenol blue
solution. Gels were loaded with 600 mg of protein in sample buffer containing
2% pharmalyte pH 3–10. IEF conditions were 500 V for 2 h and then 3500 V
to obtain 55 kV/h at 20°C. For the second dimension, IPG gels were trans-
ferred to a 12–14% SDS-polyacrylamide gradient gel (Excel-gel, 24.5 × 18 cm,
GE Healthcare) and electrophoresed at 20 mA, 1000 V and 40 W at 15°C.
2-DE gels were stained with Coomasie blue.
Western blotting. Proteins separated in the 2-D PAGE gels were elec-
trotransferred according to Barea et al. [1] to an Immobilon P membrane
(Millipore, Billerica, USA) using a semidry transfer system at 400 mA for 2 h.
The membrane was treated with blocking solution containing 5% non-fat
skim milk powder in PBS for 1 h at 37°C. After blocking, the samples were
incubated with the blood donor or patient sera diluted 1/1000 or 1/5000 in
PBS, respectively, for 1 h at 37°C. Antigen-antibody reactions were visual-
ized after the addition of anti-human IgG-horseradish peroxidase (HRP)
conjugate (Sigma, St. Louis, MO, USA) at a dilution of 1/5000 in PBS and
detected by the chemiluminescence of peroxidase activity (ECL, GE
Healthcare), according to the manufacturer’s instructions. The blot was then
wrapped in plastic and exposed to X-ray film (Curix RP-2, Agfa-Gevaert
NV, Mortsel, Belgium). Monoclonal antibodies A2C7 (Sigma) and anti-heat-
shock protein 70 (Sigma) were used to identify enolase [1] and heat-shock
protein of 71 kDa. Anti-glyceraldehyde-3-phosphate dehydrogenase of Sac-
charomyces cerevisiae [4] and pyruvate kinase polyclonal antibodies were
used to identify glyceraldehyde-3-phosphate dehydrogenase and pyruvate
kinase, respectively.
Mannoprotein detection by Con A-HRP. After electrotransfer,
membranes were incubated in 10% BSA in TBS (150 mM NaCl in 50 mM
Tris-HCl, pH 7.5) for 1 h at 37°C and then washed twice with buffer A (TBS
containing 1 mM MgCl2, 1 mM MnCl2, and 1 mM CaCl2). After incubation
with Con A-HRP (Sigma) in buffer A (0.2 mg/ml), mannoproteins were visu-
alized by chemiluminescence detection (ECL).
Protein microsequencing. Protein spots were excised and identified
by Edman degradation (in the Proteomics Laboratory of the Centro Nacional
de Biotecnología, Cantoblanco, Madrid) or by LC-MS/MS using a Q-Tof
micro mass spectrometer (Waters, Milford, MA, USA) at the Proteomics
facility of the University of the Basque Country, Bilbao, Spain). Identities
between microsequencing data and protein sequences were either searched
in SWISS-PROT, TrEMBL or were used to search protein databases for
homologous proteins with NCBI’s Basic Local Alignment Search tool
(BLAST) or FASTA programs in Candida DB (Pasteur Institute, Paris,
France). 
Image analysis. X-ray films and silver-stained gels were analyzed with
the BioImage 50S system and the 2D Protein Analyzer software (Millipore)
in a Sparc 4 station (SUN Microsystems, Madrid, Spain). Each gel was
reproduced at least five times, including biological and technical replicates.
Differences in individual quantification of proteins showed a standard error
<10%.
Results and Discussion
Two-dimensional electrophoresis is an optimal technique to
characterize protein profiles of complex extracts. When used
in combination with Western blot and enhanced chemilumi-
nescence, 2-DE is a powerful tool to establish antigen-anti-
body reactions. In this study, 12–14% 2-DE was used to dis-
criminate about 500 protein spots in blastoconidium and
germ-tube extracts of C. albicans (Fig. 1A,B). In general, the
molecular masses of the peptides ranged from 10 to 116 kDa,
and isoelectric points (pI) from 4 to 8. Protein profiles obtained
in this study were similar to those described in C. albicans
blastoconidium extracts by our group [1] and by Pitarch et al.
[23], although in the latter study the extraction procedure was
different and a non-linear pH gradient was used. 
Data obtained in this study showed that there are protein
spots specifically or preferentially associated with each mor-
phological phase (squares in Fig. 1A,B). However, other
authors have not been able to identified antigenic differences
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between blastoconidium and germ-tube extracts using 2-DE
[15,19]. Spots overexpressed in our study were identified as
methionine synthase (Mete), aconitate hydratase (Acon),
glyceraldehyde-3-phosphate dehydrogenase (Gap1p), pyru-
vate kinase (Cdc19), and enolase (Eno). Although these
enzymes have been described as immunogens by other
authors [22–24,29], they did not show immunoreactivity in
this study, with the exception of enolase (antigen no. 105).
Very different patterns of reactivity were observed between
sera from patients with invasive candidiasis (Fig. 1C,D) and
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Fig. 1. Two-dimensional electrophore-
sis (2-DE) of C. albicans blastoconidia
(A, C, E, G) and germ-tube (B, D, F,
H) extracts stained with Coomassie
blue (A, B), serum from a patient with
systemic candidiasis (C, D), serum
from a control blood donor (E, F), and
Concanavalin A (G, H). Identified pro-
teins are circled and numbered. Squares
indicate proteins that showed differen-
tial expression in one of the Candida
growth phases. Mete, methionine syn-
thase; Acon, aconitate hydratase;
Cdc19, pyruvate kinase; Gap1p, glycer-
aldehyde-3-phosphate dehydrogenase.
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from blood donors (Fig. 1E,F), as determined by Western
blotting. Antibodies present in sera from patients with inva-
sive candidiasis showed higher reactivity than control sera,
although the concentrations of control sera were five times
higher than those of patient sera. Control sera showed a very
weak reaction in three spots (1, 2, 4), thus allowing good dis-
crimination between control and patient sera. The most strik-
ing difference between the two groups of sera concerned a
polydispersed area in the acidic high- to medium-molecular-
mass regions of both extracts (Fig. 1C,D). Similar results
were obtained with the ten sera from patients with candidia-
sis (data not shown). Sixteen antigens were characteristically
recognized, ten of them in both extracts, with relative molec-
ular masses of 22–24, 44–48, and 38–39 kDa and pI between
5.4 and 8 (spots 1, 2, 93, 95, 105, 113, 119, 138, 141, 148).
Antigens 5–8 were found in blastoconidia extracts only and
showed relative molecular masses between 14 and 17 kDa
and pI of 4.3–5.3. Antigens 3 and 4 were found only in the
germ-tube extracts and had molecular masses of 16–17 kDa
and pI of 4.9–5.3.
The number of antigenic regions revealed in the reactions
between sera from patients with invasive candidiasis and the
extracts was higher than that found by Pitarch et al. [23] in
their blastoconidium cytoplasmic extracts. The differences
are probably due to the type of extract used in each study,
since we used a complete extract. In addition, our extract was
enriched in cell-wall mannoproteins, as revealed by Con A
staining, and mannans and mannoproteins are highly
immunogenic for humans [27]. Most antigens recognized by
sera from patients with invasive candidiasis had a mannopro-
tein nature (Fig. 1G,H). In general, the blastoconidium
extract showed a higher reactivity with Con A than the germ-
tube extract, which suggested that the latter should contain
more mannose groups. The detection by patient sera and Con
A of antigens 3 and 4 in the germ-tube extract and antigens
6–8 in the yeast extract suggested an immunogenic role of
the mannosylation of these peptides. Also, mannosylation of
the polydispersed area seems to be related to antigenicity
because no reaction with patient sera was detected after
metaperiodate oxidation (data not shown).
The identification and characterization of antigens rele-
vant for the serodiagnosis of invasive candidiasis is an
important step in the development of future diagnostic tests.
In this study, eight immunodominant antigens were identified
by their reactivity with monoclonal antibodies or by microse-
quencing (Table 1). Spot 105 was identified as enolase by its
reactivity with monoclonal antibody A2C7. Enolase is an
immunodominant antigen of C. albicans that was recognized
in our study by 80% of the sera from patients with invasive
candidiasis and by none of the control sera. Detection of anti-
enolase antibodies has been shown to be useful in the diag-
nosis [13] and prognosis of invasive candidiasis [24]. 
Only seven of the antigens submitted to protein microse-
quencing produced a sequence that could be used to search
the protein databases. Pardo et al. [22] attributed the lack of
a conclusive identification by MALDI-TOF mass spectrom-
etry of C. albicans cytoplasmic proteins to the fact that this
yeast is poorly characterized at the protein level. However,
the complete genome sequence of C. albicans is now avail-
able, which will certainly improve protein characterization
[14]. The N-terminal sequence data from the spots or mass
spectrometry identification are summarized in Table 1. 
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Table 1. Sequence and homologies of identified spots from the Candida albicans protein extract
Spot Sequencea Accession numberb -Protein name Immunodetection Mrc pIc
2 ALENPERP P46273 - Phosphoglycerate kinase Human sera 23.9 5.7
3 XS/LEKXTK CA4991 - Diacylglycerol kinase catalytic domain Human sera 16.6 4.9
4 TLDVLRAA CA5164 - Mitochondrial malate dehydrogenase Human sera 17 5.3
5 XIFAKXL Q5A8Y1 - Mitochondrial complex I chaperone Human sera 14.4 5.3
8 XLENKEFP/L 013359 - Kexin precursor Human sera 14.8 4.8
105 P30575 - Enolase Human sera and MAb 45–50 5.5–6.0
141–148 APPAVLSK Q9URB4 - Fructose biphosphate aldolase Human sera 38–40 6.1–6.7
aPeptide sequence obtained by Edman degradation.
bAccession number of homologous protein in protein databases (SWISS-PROT, TrEMBL, NCBI or Candida DB).
cMolecular mass (Mr) and Isoelectrical point (pI) were obtained by 2D Analyzer Software (Millipore) on 2-DE gels.
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A search of the databases with the sequence ALENPERP
from spot 2 revealed 100% homology with the phosphogly-
cerate kinase from C. albicans. This glycolytic enzyme is a
cytoplasmic and cell-wall protein known to elicit an immune
response [23,29]. Peptide number 3 yielded the sequence
XS/LEKXTK, which showed homology with the diacylgly-
cerol kinase catalytic domain of Candida albicans. Ours is
the first report of the immunogenic properties of this peptide,
which showed immunogenic activity in germ-tube extracts
only. Since the peptide was detected by ConA, mannosyla-
tion may be related to its antigenicity. Sequence TLDVL-
RAA, from antigen number 4, showed 100% homology with
C. albicans malate dehydrogenase. This enzyme, which is
inducible and has a pI of 5.5, plays an important role in the
transport system (malate-aspartate shuttle) of NADH gener-
ated by the oxidation of methanol in the mitochondria [31].
Malate dehydrogenase has been reported to be a major aller-
gen in Malassezia [21] and is immunogenic in a murine
model [24].However, our study reports, for the first time, that
this enzyme is recognized by sera from patients with invasive
candidiasis but not by control sera. 
Antigen number 5 yielded the sequence XIFAKXL,
which showed homology with a potential mitochondrial
complex I assembly chaperone of Candida albicans [12].
Sequence XLENKEFP/L, from peptide number 8, showed
homology with a kexin precursor of C. albicans. This mem-
brane protein is a Kex2 protease that belongs to peptidase
family S8; it has been shown to influence C. albicans pro-
teinase secretion and hyphal formation [18]. To our knowl-
edge, this is the first report describing an immunogenic role
for this protein. A number of Candida antigens with protease
activity have been used as targets for antibody detection,
including a secreted aspartyl proteinase [17] and a metallo-
peptidase [6]. The sequence XAPPAVLSK, from spots
141–148, showed complete homology with fructose biphos-
phate aldolase. This enzyme reacts with IgE antibody from
allergic patients [10] and was immunodetected by sera from
infected mice [24]. All sera from patients with invasive can-
didiasis but none of the controls used in this study recognized
this glycolytic enzyme.
The reactivity of the control sera was very homogeneous
against most of the antigens described. Only two control sera
showed very limited recognition of antigens 1, 2, 3, and 4.
While sera from patients with invasive candidiasis showed
higher variability, antigens 1, 2, 4, 138, and 141 were recog-
nized by all sera from patients with invasive candidiasis.
In conclusion, we identified eight antigens of potential
interest for the serodiagnosis of invasive candidiasis. As far
as we know, this is the first time that three of those antigens
(kexin precursor, a mitochondrial complex I chaperone, and
a diacylglycerol kinase catalytic domain) have been des-
cribed as immunogenic for humans. 
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